Adolescent- and Young Adult-Reported Outcomes and Use of Continuous Glucose Monitoring Features: A Report from the CGM Intervention in Teens and Young (CITY) Trial
Authors' conclusion
Improvements in self-reported measures were observed in adolescents and young adults using CGM. As CGM use is also associated with better glycemic control, utilizing CGM may contribute to improving both medical outcomes and emotional health.
Study context
- Population
- Adolescents/young adults with T1D
- Comparison
- Continuous glucose monitor (CGM) continued vs CGM initiated after blood glucose meter (BGM)
Methodological details1:1 randomisation, 26-week randomized clinical trial (RCT) followed by 26-week extension
- 1:1 randomisation
- 26-week RCT followed by 26-week extension
Primary result
As reported in the abstract
up to 52 weeks
Participants wearing CGM >5 days/week at 52 weeks, both cohorts
>70%
Discontinued CGM
5%
Used SHARE features: adolescents (14 to <19 years) vs young adults
80% vs 41%
Original publication
Adolescent- and Young Adult-Reported Outcomes and Use of Continuous Glucose Monitoring Features: A Report from the CITY Trial. Pediatr Diabetes. Published 15 September 2023. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →